Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer

Background. Gastric cancer (GC) is one of the most prevalent cancers globally. This study was designed to evaluate the potential performance of plasma SEPT9 methylation (mSEPT9) as a noninvasive biomarker for the diagnosis of GC. Methods. A total of 182 participants, i.e., 60 patients with GC, 39 wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Luyao, Li, Muran, Zhang, Shiwu, Liu, Yandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656015/
https://www.ncbi.nlm.nih.gov/pubmed/36362627
http://dx.doi.org/10.3390/jcm11216399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656015/
https://www.ncbi.nlm.nih.gov/pubmed/36362627
http://dx.doi.org/10.3390/jcm11216399

Ejemplares similares